Moderna
MRNA
#1162
Rank
C$26.92 B
Marketcap
C$67.88
Share price
-0.87%
Change (1 day)
85.94%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Moderna (MRNA) - Total debt

Total debt on the balance sheet as of December 2025 : C$1.81 Billion

According to Moderna 's latest financial reports the company's total debt is C$1.81 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Moderna - Total debt on balance sheet (from 2017 to 2025)

Total debt by year

Year Total debt Change
2025-12-31C$1.78 B66.72%
2024-12-31C$1.07 B-34.98%
2023-12-31C$1.64 B1.25%
2022-12-31C$1.62 B39.49%
2021-12-31C$1.16 B286.31%
2020-12-31C$0.30 B74.8%
2019-12-31C$0.17 B278.96%
2018-12-31C$45.61 M131.3%
2017-12-31C$19.72 M17.41%
2016-12-31C$16.79 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
C$66.71 B 3,573.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$49.23 B 2,610.80%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
C$68.67 B 3,680.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
C$1.94 M-99.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
C$25.85 M-98.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
C$1.77 B-2.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
C$0.43 B-76.03%๐Ÿ‡บ๐Ÿ‡ธ USA